Santen Pharmaceutical Co., Ltd. Appoints Luis Iglesias as Corporate Officer Head of Santen EMEA and Ken Araki as Corporate Officer Head of Global Business Development Department, Effective October 1, 2018
September 13, 2018 at 08:00 am
Share
Santen Pharmaceutical Co., Ltd. appointed Luis Iglesias as Corporate Officer Head of Santen EMEA, currently Head of Santen EMEA and Ken Araki as Corporate Officer Head of Global Business Development Department, currently Head of Global Business Development Department, effective October 1, 2018.
SANTEN PHARMACEUTICAL CO., LTD. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing and sales of pharmaceutical products. The Company has medical pharmaceutical business, OTC drugs business, medical devices business and other businesses. The Company engages in manufacture, sale and clinical development of medical pharmaceutical products, the development, manufacturing and sales of medical equipment, as well as the cleaning business. The Company operates in Japan, Europe, Asia, North America markets.
Santen Pharmaceutical Co., Ltd. Appoints Luis Iglesias as Corporate Officer Head of Santen EMEA and Ken Araki as Corporate Officer Head of Global Business Development Department, Effective October 1, 2018
SANTEN PHARMACEUTICAL CO., LTD. 
